Tetris Deal Falls Into Place For UK’s Aspire
Aspire Pays £0.5m For UK Rights To Multiple Products From Arecor Subsidiary
Niche generics company Aspire Pharma has struck a deal to acquire a portfolio of products from fellow UK firm Tetris Pharma as it is wound up, paying Tetris parent Arecor £0.5m for UK distribution rights and inventory.
